openPR Logo
Press release

Influenza Vaccine Market Outlook 2017: Opportunity,Demand Analysis and Market Forecast

08-25-2017 04:11 PM CET | Health & Medicine

Press release from: DPI Research

dpi

dpi

United States flu vaccine market is expected to reach nearly US$ 3 Billion by 2024.

Growth in US flu vaccine market can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against flu vaccine and introduction of quadrivalent flu vaccine.

Long–term Growth Projection and Development:

• Sanofi to Acquire Protein Sciences Corporation

• It is likely that more than 185 Million persons being vaccinated with flu vaccines in 2024

• Nearly 160 Million doses of flu vaccines have shipped to US for the 2017-2018 flu season

• It is projected that GSK flu vaccine sales value will reach around US$ 1.5 Billion by 2024

• BiondVax reports positive phase 2b clinical trial results for its universal flu vaccine

“Flu Vaccine Market Outlook 2024: United States Opportunity and Demand Analysis, Market Forecast 2017-2024” provides a deep and thorough evaluation of the United States flu vaccine market. The report provides an in–depth analysis of the flu vaccination pattern in both Children and Adults in the United States. It also provides essential insights into flu vaccine production, price, consumption, supply, distribution, demand and specification. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and promising flu vaccines in the clinical development. Key trends in terms of M&A, collaborations and licensing agreements are analyzed with details.

The report concludes with the profiles of major players in the US flu vaccine market such as Sanofi Pasteur, GSK and Seqirus. The major market players are evaluated on various parameters such as company overview, product outlook, latest development & trends and sales analysis of flu vaccine market from 2011 to 2022. The report also entails major drivers and inhibitors in the US flu vaccine market.

Complete Report @ http://www.dpiresearch.com/report-details.php?P_ID=110

Key Topics Covered in the Report

• Market Overview: United States Flu Vaccine Market (2010 - 2024)
• United States Number of Persons Vaccinated with Flu Vaccine (2010 - 2024)
• United States Flu Vaccine Production, Price, Consumption, Supply, Distribution, Demand and Specification
• Reimbursement & Regulatory System in the US Flu Vaccine Market
• Mergers, Acquisitions, Key Agreements & Collaborations
• Promising Flu Vaccine in Clinical Development
• Flu Vaccine Clinical Trial Insights by Phase, Company & Country
• Key Drivers and Inhibitors of the US Flu Vaccine Market
• Key Companies Analysis

Major Flu Vaccines Covered Under This Report Are:

• Fluzone High–Dose
• Fluzone Quadrivalent
• Intradermal (ID) Trivalent
• Vaxigrip
• Fluarix Quadrivalent
• Flulaval Quadrivalent
• Flucelvax Quadrivalent
• Afluria Quadrivalent
• Agrippal
• Fluad
• Fluvirin
• Fluvax

Key Companies Covered in This Report:

• Seqirus
• Sanofi Pasteur
• GlaxoSmithKline(GSK)

DPI Research is a business solutions firm which offer bespoke market research reports, custom research solutions and consulting across multi geographies and industry verticals. We deliver wide range of cutting-edge research solutions that helps organizations in making better decisions of the business to business needs.

DPI Research provides high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to use advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for the business research led by a team of dynamic industry experts. DPI Research provides a real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reach across the globe with global standards from established markets in the North America and Europe to emerging markets in South America, Asia-Pacific, Middle East and Africa to provide the best business solutions.

Maria Rai
Tel :+91 -7289949987
Email: sales@dpiresearch.com
Website: www.dpiresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Influenza Vaccine Market Outlook 2017: Opportunity,Demand Analysis and Market Forecast here

News-ID: 685344 • Views:

More Releases from DPI Research

China Non-Invasive Prenatal Testing Market Growth, Share, Size, Trends and Forecast (2024 - 2032)
China Non-Invasive Prenatal Testing Market Growth, Share, Size, Trends and Forec …
China Non-Invasive Prenatal Testing Market Growth, Share, Size, Trends and Forecast (2024 - 2032) As per DPI Research latest published report, the China Non-Invasive Prenatal Testing (NIPT) market size was valued at US$ 608 Million in 2023 and it is forecasted to reach US$ 1,083 Million by the year end of 2032. China non invasive prenatal testing (NIPT) market compound annual growth rate will be 7.04% from 2024 to 2032. This new
India Outbound MICE Tourism Market worth US$ 13.4 Billion by 2030|DPI Research
India Outbound MICE Tourism Market worth US$ 13.4 Billion by 2030|DPI Research
DPI Research has published a new research report titled "India Outbound Meetings, Incentives, Conferences and Exhibitions (MICE) Tourism Market 2023: Outlook, Trends, Opportunities and Forecasts to 2031" in its research database. According to the latest research study 2023, India Outbound Meetings, Incentives, Conferences and Exhibitions (MICE) tourism market size is expected to reach US$ 13.4 billion by 2031. The Indian Outbound Tourism (MICE) is experiencing significant growth due to a
India's Outbound Tourism Market Is Expected To Boost By 11% CAGR Between 2023 And 2031: DPI Research Report
India's Outbound Tourism Market Is Expected To Boost By 11% CAGR Between 2023 An …
[230+ Pages Latest Report] According to a market research study published by DPI Research, India's outbound tourism market size is expected to reach $60 billion by 2031, growing at a CAGR of 10.9% over the forecast period 2023-2031. Rising personal income levels and greater accessibility will enable international travel for a greater proportion of India's population. India's sizable global diasporas and international student body will continue to be a pull factor
United States Non Invasive Prenatal Testing (NIPT) Market Size 2023 - 2031 | Key Players Illumina Inc., Natera Inc., Quest Diagnostics, Myriad Genetics, Inc. Centogene, GenPath, PerkinElmer, Yourgene Health, Invitae Corporation, Agilent Technologies, Ario
United States Non Invasive Prenatal Testing (NIPT) Market Size 2023 - 2031 | Key …
The research report on the NIPT Test Market, released by DPI Research, offers a comprehensive analysis of the US industry. The report provides valuable insights into the market's size, share, and industry trends, along with a detailed breakdown of products and services. It presents key statistics regarding the market's status, growth factors, and upcoming trends. The report also discusses the potential industrial opportunities and growth scenarios for the NIPT Test

All 4 Releases


More Releases for Flu

Microneedle Flu Vaccine Market New develop microneedle patch for flu vaccination
Drug delivery through the skin by transdermal patches has always been effective against viral infection and flu. Drug delivery through transdermal route is mainly effective due to passive diffusion of the drug and followed by drug development in transdermal delivery systems through different mechanism of action such as iontophorresis and sonophoresis. Moreover, pharmaceutical companies are focusing on development of micro-needle vaccines due to its immense utility in transdermal delivery of
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Researchers Develop Microneedle Flu Vaccine for flu vaccination
New research funding to develop commercially available micro needle flu vaccine, which would pace up the launch of these products. In 2015, the Georgia Institute of Technology and Micron Biomedical were awarded US$ 2.5 million in grants from the Bill & Melinda Gates Foundation to advance the development of dissolvable microneedle patches for polio immunization. This would also widen up the disease profile for which microneedle vaccine could be developed. Growing
Global Flu Vaccine Market Research Report
This report studies the global Flu Vaccine market status and forecast, categorizes the global Flu Vaccine market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Sanofi-pasteur Novartis GSK Abbott Pfizer CSL Hualan Bio Changchun Bio Alephbio Sinovac CS Vaccine Tianyuan Bio Tiantan
Canine Flu Therapeutics Market 2019| To Develop Therapeutics For The Flu To Cont …
"Canine Flu Therapeutics Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028" is the latest addition to MarketResearchReports.Biz industry research reports collection. Canine flu (also known as dog flu) is a contagious respiratory disease in dogs mainly caused by Type A influenza/canine influenza virus. They are two various kinds of influenza viruses namely H3N8 virus and H3N2. Canine flu originated in horses, spread to dogs, and now spreads in between dogs
United States Flu Vaccine Market & Forecast
United States Influenza Vaccine Market is expected to reach more than US$ 2.5 Billion by the year end of 2022. Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccine and introduction of quadrivalent influenza vaccine. The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and